Additional evidence for commonalities between COVID-19 and radiation injury: Novel insight into COVID-19 candidate drugs
F Geng, J Chen, S Tang, EI Azzam… - Radiation …, 2022 - meridian.allenpress.com
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs
F Geng, J Chen, S Tang, EI Azzam… - Radiation …, 2022 - researchwithrutgers.com
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional evidence for commonalities between COVID-19 and radiation injury: novel insight into COVID-19 candidate drugs.
F Geng, J Chen, S Tang, EI Azzam, J Zhang, S Zhang - 2022 - cabidigitallibrary.org
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs
F Geng, J Chen, S Tang, EI Azzam, J Zhang… - Radiation Research, 2022 - BioOne
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs
F Geng, J Chen, S Tang, EI Azzam… - Radiation …, 2022 - pubmed.ncbi.nlm.nih.gov
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs.
F Geng, J Chen, S Tang, EI Azzam… - Radiation …, 2022 - search.ebscohost.com
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs.
F Geng, J Chen, S Tang, EI Azzam, J Zhang… - Radiation …, 2022 - europepmc.org
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs
F Geng, J Chen, S Tang, EI Azzam, J Zhang… - Radiation Research, 2022 - BioOne
COVID-19 is a challenge to biosecurity and public health. The speed of vaccine
development lags behind that of virus evolution and mutation. To date, no agent has been …
development lags behind that of virus evolution and mutation. To date, no agent has been …